| Pimozide |
Influence on protein activity |
Western Blot |
10.00 µM |
K562 |
Homo sapiens |
|
p-STAT5 |
|
| Pimozide |
Influence on protein activity |
Western Blot |
10.00 µM |
K562 |
Homo sapiens |
|
STAT5 |
|
| Pimozide |
Influence on protein activity |
Western Blot |
10.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on protein activity |
Western Blot |
10.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on protein activity |
Western Blot |
10.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on protein activity |
Western Blot |
10.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
2.50 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on protein activity in presence of nilotinib |
Western Blot |
5.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on protein activity in presence of nilotinib |
Western Blot |
5.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability in presence of nilotinib |
ATP-dependent luminescence assay |
5.00 µM |
K562 |
Homo sapiens |
|
|
|
